Condition

Female Orgasmic Disorder (3)

Female Sexual Arousal Disorder (1)

Hypoactive Sexual Desire Disorder (1)

Major Depressive Disorder (1)

Post-traumatic Stress Disorder (1)

Overall Status

Completed (2)

Unknown status (1)

Phase

phase 2 (2)

n/a (1)

Sponsor

Acerus Pharmaceuticals Corporation (1)

Center for Vulvovaginal Disorders (1)

University of Texas at Austin (1)

Collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

Intervention

expressive writing (1)

high dose tbs-2 (1)

low dose tbs-2 (1)

medium dose tbs-2 (1)

peri-urethral and clitoral injections (1)

placebo (1)

Study Documents

Informed Consent Form (1)

Intervention Type

behavioral (1)

biological (1)

drug (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

female orgasmic disorder

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Female Orgasmic Disorder Trial in Australia, Canada, United States (Placebo, Low dose TBS-2, Medium dose TBS-2)

Completed

Has Results

Female Orgasmic Disorder

Placebo
+3 more

Birmingham, Alabama
+52 more

Aug 9, 2018

Female Orgasmic Disorder Trial in Washington, D.C. (Peri-urethral and clitoral injections)

Unknown status

Female Orgasmic Disorder

Peri-urethral and clitoral injections

Washington, D.C., District of Columbia

The Center for Vulvovaginal Disorders

Jun 23, 2017

Hypoactive Sexual Desire Disorder, Female Sexual Arousal Disorder, Female Orgasmic Disorder Trial in Austin (Expressive writing)

Completed

Hypoactive Sexual Desire Disorder
+4 more

Expressive writing

Austin, Texas

University of Texas at Austin

Dec 1, 2014